Financial reports
20-F
2023 FY
Annual report (foreign)
6 Mar 24
20-F
2022 FY
Annual report (foreign)
15 Mar 23
20-F
2021 FY
Annual report (foreign)
15 Mar 22
20-F
2020 FY
Annual report (foreign)
24 Feb 21
20-F/A
2019 FY
Annual report (foreign) (amended)
16 Mar 20
20-F
2019 FY
Annual report (foreign)
26 Feb 20
20-F
2018 FY
Annual report (foreign)
27 Feb 19
20-F
2017 FY
Annual report (foreign)
6 Mar 18
20-F
2016 FY
Annual report (foreign)
1 Mar 17
20-F
2015 FY
Annual report (foreign)
25 Feb 16
Current reports
6-K
Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America
22 Jan 25
6-K
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
8 Jan 25
6-K
Report of Foreign Private Issuer
11 Dec 24
6-K
Kamada Reports Continued Profitable Growth with Strong Third Quarter and Nine Month 2024 Financial Results; Raises Full-Year Profitability Guidance
13 Nov 24
6-K
Report of Foreign Private Issuer
6 Nov 24
6-K
Kamada to Present at the Stifel 2024 Healthcare Conference
4 Nov 24
6-K
Notice of Annual General Meeting of Shareholders
21 Oct 24
6-K
Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston
23 Sep 24
6-K
Report of Foreign Private Issuer
14 Aug 24
6-K
Report of Foreign Private Issuer
7 Aug 24
Registration and prospectus
F-3
Shelf registration (foreign)
11 Sep 23
S-8
Registration of securities for employees
28 Jun 22
S-8
Registration of securities for employees
14 Aug 19
S-8
Registration of securities for employees
6 Feb 18
424B5
Prospectus supplement for primary offering
1 Aug 17
424B5
Prospectus supplement for primary offering
27 Jul 17
F-3/A
Shelf registration (foreign) (amended)
13 Jul 17
S-8
Registration of securities for employees
9 Feb 17
F-3
Shelf registration (foreign)
28 Nov 16
S-8
Registration of securities for employees
10 Nov 15
Proxies
No filings
Other
EFFECT
Notice of effectiveness
15 Sep 23
CORRESP
Correspondence with SEC
13 Sep 23
UPLOAD
Letter from SEC
12 Sep 23
UPLOAD
Letter from SEC
2 Aug 19
CORRESP
Correspondence with SEC
18 Jul 19
UPLOAD
Letter from SEC
8 Jul 19
CT ORDER
Confidential treatment order
19 Mar 19
EFFECT
Notice of effectiveness
13 Jul 17
CORRESP
Correspondence with SEC
13 Jul 17
CORRESP
Correspondence with SEC
12 Jul 17
Ownership
SC 13G/A
Phoenix Financial Ltd.
14 Nov 24
SC 13G/A
Gov Financial Holdings Ltd.
14 Feb 24
SC 13G/A
Phoenix Holdings Ltd.
12 Feb 24
SC 13G/A
Phoenix Holdings Ltd.
28 Dec 23
SC 13G/A
Phoenix Holdings Ltd.
19 Dec 23
SC 13D/A
DAVIDI ISHAY
7 Sep 23
SC 13D/A
DAVIDI ISHAY
24 May 23
SC 13G/A
Phoenix Holdings Ltd.
14 Feb 23
SC 13G/A
Phoenix Holdings Ltd.
7 Feb 22
SC 13G/A
Phoenix Holdings Ltd.
9 Nov 21